Publication: NSAID-activated gene-1 as a molecular target for capsaicin-induced apoptosis through a novel molecular mechanism involving GSK3β, C/EBPβ and ATF3
| dc.contributor.author | Lee S.-H. | |
| dc.contributor.author | Krisanapun C. | |
| dc.contributor.author | Baek S.J. | |
| dc.date.accessioned | 2021-04-05T03:36:54Z | |
| dc.date.available | 2021-04-05T03:36:54Z | |
| dc.date.issued | 2010 | |
| dc.date.issuedBE | 2553 | |
| dc.description.abstract | Capsaicin, a natural product of the Capsicum species of red peppers, is known to induce apoptosis and suppress growth. Nonsteroidal anti-inflammatory drug-activated gene-1 (NAG-1) is a cytokine associated with pro-apoptotic and antitumorigenic property in colorectal and lung cancer. Our data demonstrate that capsaicin leads to induction of apoptosis and up-regulates NAG-1 gene expression at the transcriptional level. Overexpression of CCAAT/enhancer binding protein β (C/EBPβ) caused a significant increase of basal and capsaicin-induced NAG-1 promoter activity. We subsequently identified C/EBPβ binding sites in the NAG-1 promoter responsible for capsaicin-induced NAG-1 transactivation. Electrophoretic mobility shift assay and chromatin immunoprecipitation assay confirmed binding of C/EBPβ to the NAG-1 promoter. Capsaicin treatment resulted in an increase of phosphorylated serine/threonine residues on C/EBPβ, and the immunoprecipitation study showed that capsaicin enhanced binding of C/EBPβ with glycogen synthase kinase 3β (GSK3β) and activating transcription factor 3 (ATF3). The phosphorylation and interaction of C/EBPβ with GSK3β and ATF3 are decreased by the inhibition of the GSK3β and Protein Kinase C pathways. Knockdown of C/EBPβ, GSK3β or ATF3 ameliorates NAG-1 expression induced by capsaicin treatment. These data indicate that C/EBPβ phosphorylation through GSK3β may mediate capsaicin-induced expression of NAG-1 and apoptosis through cooperation with ATF3 in human colorectal cancer cells. © The Author 2010. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected]. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | Carcinogenesis. Vol 31, No.4 (2010), p.719-728 | |
| dc.identifier.doi | 10.1093/carcin/bgq016 | |
| dc.identifier.issn | 1433334 | |
| dc.identifier.other | 2-s2.0-77950896712 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14740/7631 | |
| dc.rights.holder | Scopus | |
| dc.subject.other | Activating transcription factor 3 | |
| dc.subject.other | Capsaicin | |
| dc.subject.other | CCAAT enhancer binding protein beta | |
| dc.subject.other | Glycogen synthase kinase 3beta | |
| dc.subject.other | Nonsteroid antiinflammatory drug activated gene 1 protein | |
| dc.subject.other | Protein kinase C | |
| dc.subject.other | Unclassified drug | |
| dc.subject.other | Activating transcription factor 3 | |
| dc.subject.other | ATF3 protein, human | |
| dc.subject.other | CCAAT enhancer binding protein beta | |
| dc.subject.other | GDF15 protein, human | |
| dc.subject.other | Glycogen synthase kinase 3 | |
| dc.subject.other | Glycogen synthase kinase 3 beta | |
| dc.subject.other | Growth differentiation factor 15 | |
| dc.subject.other | Protein kinase C | |
| dc.subject.other | Retinoic acid receptor | |
| dc.subject.other | Retinoic acid receptor alpha | |
| dc.subject.other | Antineoplastic activity | |
| dc.subject.other | Apoptosis | |
| dc.subject.other | Article | |
| dc.subject.other | Binding site | |
| dc.subject.other | Cancer cell culture | |
| dc.subject.other | Cancer inhibition | |
| dc.subject.other | Colorectal cancer | |
| dc.subject.other | Controlled study | |
| dc.subject.other | Drug targeting | |
| dc.subject.other | Gene expression regulation | |
| dc.subject.other | Human | |
| dc.subject.other | Human cell | |
| dc.subject.other | Priority journal | |
| dc.subject.other | Promoter region | |
| dc.subject.other | Protein phosphorylation | |
| dc.subject.other | Protein protein interaction | |
| dc.subject.other | Signal transduction | |
| dc.subject.other | Transactivation | |
| dc.subject.other | Upregulation | |
| dc.subject.other | Cell strain HCT116 | |
| dc.subject.other | Cell strain HT29 | |
| dc.subject.other | Colorectal tumor | |
| dc.subject.other | Drug effect | |
| dc.subject.other | Genetics | |
| dc.subject.other | Pathology | |
| dc.subject.other | Phosphorylation | |
| dc.subject.other | Physiology | |
| dc.subject.other | Activating Transcription Factor 3 | |
| dc.subject.other | Apoptosis | |
| dc.subject.other | Capsaicin | |
| dc.subject.other | CCAAT-Enhancer-Binding Protein-beta | |
| dc.subject.other | Colorectal Neoplasms | |
| dc.subject.other | Glycogen Synthase Kinase 3 | |
| dc.subject.other | Growth Differentiation Factor 15 | |
| dc.subject.other | HCT116 Cells | |
| dc.subject.other | HT29 Cells | |
| dc.subject.other | Humans | |
| dc.subject.other | Phosphorylation | |
| dc.subject.other | Promoter Regions, Genetic | |
| dc.subject.other | Protein Kinase C | |
| dc.subject.other | Receptors, Retinoic Acid | |
| dc.subject.other | Signal Transduction | |
| dc.title | NSAID-activated gene-1 as a molecular target for capsaicin-induced apoptosis through a novel molecular mechanism involving GSK3β, C/EBPβ and ATF3 | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| swu.datasource.scopus | https://www.scopus.com/inward/record.uri?eid=2-s2.0-77950896712&doi=10.1093%2fcarcin%2fbgq016&partnerID=40&md5=7ef49bbc4305395fb1ce96014e605e74 |
